Sample digital edition
Register for a free digital subscription|
Supplement to Managed Care: Continuing Education Credit  Biologic Therapy Management: The Need For Value-Based Health Benefits Models Free download |
Vol. 14, No. 9
September 2005
The Private Sector Meets the Uninsured
Leonard Schaeffer, chairman of WellPoint, insists that the needs of much of the uninsured population can be met by insurers. Can you hear opportunity knocking?
Specialty Hospitals Under Scrutiny
Physician-owned specialty hospitals are a contentious issue and unless a federal moratorium on their construction is reinstated, it could get even uglier. Some health plans think that such facilities harm community hospitals.
Once only a blip on the radar screen of health care costs, specialty pharmaceutical prices have been climbing at nearly twice the rate of traditional pharmaceuticals. Here are the latest management techniques.
Al Lewis Sets DM Right (Again!)
The godfather of disease management says that some of the skepticism surrounding ROI over the years has been warranted. Now, he aims to make it so that health plans and employers can have faith in the numbers.
Should coverage be mandated?
How to spot biased drug research.
DM's out to please Medicare.
News and Commentary
New Research Throws Doubt On DM's Cost-Effectiveness
HMO profits up, but at a much slower rate [chart]
Doc Buy-In Needed For EHR Push
Some Elderly Not Helped by Guidelines
Improving Processes Easier Said Than Done
Headlines On Deadline ...
Pharmacists benefit out West.
Copayments rise unchecked.
What cost mail order pharmacy?
Dual therapy for Parkinson's.
Stable claims, but rising biologics costs.